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Available online 6 August 2014Adoptive transfer of antigen-specific, in vitro-induced Foxp3+ Treg (iTreg) cells protects against
autoimmune disease. To generate antigen-specific iTreg cells at high purity, however, remains a
challenge. Whereas polyclonal T cell stimulation with anti-CD3 and anti-CD28 antibody yields
Foxp3+ iTreg cells at a purity of 90–95%, antigen-induced iTreg cells typically do not exceed a
purity of 65–75%, even in a TCR-transgenic model. In a similar vein to thymic Treg cell selection,
iTreg cell differentiation is influenced not only by antigen recognition and the availability of TGF-β
but also by co-factors including costimulation and adhesion molecules. In this study, we
demonstrate that blockade of the T cell integrin Leukocyte Function-associated Antigen-1 (LFA-1)
during antigen-mediated iTreg cell differentiation augments Foxp3 induction, leading to
approximately 90% purity of Foxp3+ iTreg cells. This increased efficacy not only boosts the yield
of Foxp3+ iTreg cells, it also reduces contamination with activated effector T cells, thus improving
the safety of adoptive transfer immunotherapy.
© 2014 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/3.0/).Keywords:
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Autoimmunity1. Introduction
In addition to thymic regulation, peripheral induction of a
regulatory phenotype in conventional T (Tconv) cells provides
protection from undesirable immune responses to self anti-
gens. Adoptive transfer of in-vitro induced Foxp3+ T regulatory
(iTreg) cells forms an attractive approach to therapeutically
restore the balance when healthy immunity is disturbed, i.e. in
autoimmune disease. iTreg cells can be generated at very high
purity by polyclonal stimulation of naive CD4+CD62L+ T cells
with anti-CD3 and anti-CD28 antibody in the presence of TGF-β
and IL-2 (Thornton et al., 2010; Verhagen et al., 2013a). Studies
using iTreg cells obtained in thisway fromTCR-transgenicmice
have demonstrated that antigen-specificity is an important
factor in the functionality of transferred iTreg cells (DiPaoloMolecular Medicine,
1TD, United Kingdom.
hagen).
. This is an open access article uet al., 2007; Chattopadhyay and Shevach, 2013) (personal
observation JV, unpublished). Although iTreg cells have been
the subject of intense investigation, the in vitro differentiation
of antigen-specific iTreg cells, using cognate ligand rather than
anti-CD3 and anti-CD28, at high purity remains a challenge.We
have demonstrated previously that, in the Tg4 mouse model,
iTreg cells can be generated using cognate Myelin Basic Protein
(MBP) peptide as a stimulus but the level of conversion lags
behind that achieved using antibody stimulation (65–75% vs
90–95%) (Verhagen et al., 2013a). This low purity not only
limits the yield of Foxp3+ iTreg cells, the contamination with
activated Foxp3− T cells that may exert pro-inflammatory
effector functions poses a potential risk when used for Treg
cell-based immunotherapy.
Development of Foxp3+ iTreg cells depends not only on
TCR signals and the availability of TGF-β, but also on
additional co-factors. For example, CTLA-4 has previously
been suggested to be important for TGF-β-dependent Foxp3
induction (Zheng et al., 2006), although this finding was
recently contradicted (Chattopadhyay and Shevach, 2013). Innder the CC BY license (http://creativecommons.org/licenses/by/3.0/).
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a number of costimulatory and adhesion molecules involved
in T cell activation and regulation on Foxp3 induction in vitro.
Interestingly, we found that blockade of Leukocyte Function-
associated Antigen-1 (LFA-1) with monoclonal antibody
augmented antigen-induced Foxp3 expression, giving rise to
iTreg cells approximately 90% Foxp3+. LFA-1 is an integrin
that, through interaction with its ligand ICAM-1, mediates T
cell-APC interaction and is involved in stable formation of the
immunological synapse (Shimizu, 2003). It, therefore, con-
trols the avidity of the activation signals received through the
T cell receptor and costimulatory molecules. Although
signaling through LFA-1 itself is less well defined, LFA-1
ligation has been shown to make CD4+ T cells refractory to
TGF-β signaling through upregulation of Smad7, SKI and
SMURF2 (Verma et al., 2012). We have not been able to
establish if the effect of anti-LFA-1 during iTreg differentia-
tion follows a direct or indirect impact of LFA-1 on Foxp3
induction but the result is in line with previous findings; the
prevention of allogeneic transplant rejection by treatment
with anti-LFA-1 has been shown to be associated with an
increased frequency of CD4+Foxp3+ Treg cells in the graft-
draining lymph nodes (Reisman et al., 2011). Here, we
demonstrate that our method induces antigen-specific iTreg
cells of high purity that successfully protect against CNS
autoimmune disease.
2. Materials and methods
2.1. Mice
B10.PL, Tg4, Tg4 CD45.1+ and Tg4 Foxp3gfp (Verhagen et al.,
2013a) mice were bred and kept under specific pathogen-free
conditions. All experiments were carried out under a UK Home
Office Project Licence and were subject to assessment by the
University of Bristol ethical review committee.
2.2. Peptide
The acetylated N-terminal peptide of murine MBP, Ac1-9
(Ac-ASQKRPSQR) and its high MHC affinity variant (Ac-
ASQYRPSQR) were custom synthesized (purity N 85%; GL
Biochem (Shanghai) Ltd.)
2.3. Naive T cell isolation
CD4+CD62L+ naive T cells were isolated magnetically from
splenocytes using a naive T cell isolation kit (Stemcell Technol-
ogies) according to the manufacturer's recommendations.
2.4. iTreg cell differentiation
CD4+CD62L+ naive splenic T cells were cultured in vitro
for 7 days in RPMI medium supplemented with 5% FCS, in the
presence of 100 U/ml rhIL-2 (R&D systems) and 10 ng/ml
rhTGF-β1 (Peprotech). Cells were stimulated either with anti-
CD3e (1 μg/ml) and anti-CD28 (2 μg/ml) plate-bound
antibody (both from eBioscience) or MBP Ac1-9 peptide in
the presence of irradiated B10.PL splenocytes used as
antigen-presenting cells. Where indicated, functional grade
antibody to LFA-1 (M17/4, Biolegend or eBioscience), CTLA-4(9H10, eBioscience), PD-1 (J43, BioXCell), LAG3 (C9B7W,
BioXCell) or IL-10R (1B1.3A, BioXCell) was added either
plate-bound or soluble in the medium at 10 μg/ml for the
duration of the culture. The level of FoxP3 induction was
assessed by flow cytometry.
2.5. Flow cytometry
Flow cytometric analysis was performed using an LSR II or
Fortessa X20 flow cytometer (BD). Cell phenotypes were
analyzed using combinations of anti-FoxP3-PE,−efluor450 or
–APC, anti-CD45.2-PerCPCy5.5, anti-CD45.1 PE-Cy7, anti-
CD62L-PE-Cy7, anti-Ki67-ef450, anti-CD4-AlexaFluor700 (all
from eBioscience), anti-Neuropilin-1-PE or −APC, anti-LFA-1
(clone 2D7)-PE, anti-Helios-FITC, and anti-CD103-PerCPCy5.5
(all from Biolegend) antibodies. Fixable viability dye eFluor780
(eBioscience)wasused in all experiments to exclude dead cells.
Cell proliferation dye-ef450 (CPD-ef450, eBioscience) was used
to visualize cell divisions or calculate division and proliferation
indexes. Results were analyzed using FlowJo analysis software
(Tree Star, Inc.).
2.6. Demethylation analysis
Demethylation analysis of the foxp3 CNS2 region was
carried out by EpigenDX, assay ADS568. The heat map matrix
was created using the free online tool on http://www.chibi.ubc.
ca/matrix2png/bin/matrix2png.cgi. Each block in the heat map
represents the mean of 3 individual samples per condition.
Female mice were used for the analysis. Therefore, the level of
methylation is relative, with the highest level of methylation in
any CpG in the CD4+ Tconv cell group set as themaximum and
the lowest level in any CpG in the CD4+CD25+ Treg cell group
as the minimum.
2.7. Induction and scoring of EAE
Tg4 mice, with 5 × 106 iTreg cells in PBS or PBS only
transferred i.p. on day−3, were primed subcutaneously at the
base of the tailwith 200 μg ofMBPAc1-9 in 0.1ml of a sonicated
emulsion consisting of an equal volume of complete Freund's
adjuvant (CFA) and PBS, containing 4 mg/ml of heat-killed
Mycobacterium Tuberculosis (both from Difco). On days 0 and 2,
200 ng of Pertussis toxin (Sigma Aldrich) was administered
intraperitoneally in 0.5 ml of PBS. EAE was assessed twice daily
with the following scoring system: 0, no signs; 1, flaccid tail; 2;
impaired righting reflex and/or gait; 3, hind limb paralysis; 4,
forelimb and hind limb paralysis; 5, moribund.
2.8. Statistical analysis
Data were analyzed for statistical significance using
GraphPad Prism software.
3. Results and discussion
3.1. Foxp3 expression can be induced with peptide even in
low-frequency antigen-speciﬁc Tconv cells
In experimental settings, antigen-specific iTreg cells are
commonly generated frommurine TCR-transgenic CD4+ T cells
Fig. 1. Foxp3 expression can be induced in antigen-specific Tconv cells with peptide, evenwhen at low frequency. Tg4 CD45.1+ naive CD4+ T cells were titrated down
among B10.PL (CD45.2+) naive T cells (from100down to 0.001% TCR-transgenic) before Foxp3 induction by activationwithMBPAc1-9 (1 μg/ml) in the presence of IL-2
and TGF-β1. Plots gated on live CD45.1+ cells on day 7 of differentiation culture. 1 experiment representative of 3 is shown.
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antibodies in the presence of TGF-β and IL-2 since this method
generates large numbers of Foxp3+ cells at very high purity
(Thornton et al., 2010; Verhagen et al., 2013a). Although this
method is well suited to investigating the function of antigen-
specific iTreg cells in various settings, it obviously cannot be
used to generate antigen-specific iTreg cells in a polyclonal
system.We previously showed in the Tg4mousemodel, where
N90% of CD4+ T cells recognize the MBP Ac1-9 peptide, that
Foxp3 can be induced in Tconv cells by stimulation with
cognate peptide in the presence of irradiated APCs, TGF-β and
IL-2 (Verhagen et al., 2013a). To demonstrate that antigen-
specific Tconv cells in a polyclonal system, where theirFig. 2. LFA-1 modulates antigen-specific Foxp3 induction. A: Foxp3 induced in CD4+
without anti-CTLA-4,−PD-1,−LFA-1 or -LAG3, either plate-bound or soluble (al
more similar experiments. ***P b 0.001, One-way ANOVA with Dunnett's post-tes
cells stimulated with 1 μg/ml MBP Ac1-9 and irradiated APC, in the presence or abs
of three similar experiments. C: Foxp3 induction in CD4+CD62L+ Tg4 T cells after 7
without 10 μg/ml soluble anti-LFA-1. Top; percentage of Foxp3+ cells among l
CD4+Foxp3+ cells. n = 6–8 individual experiments per condition. **P b 0.01, ***P
labeled with CPD-ef450 after 7-day iTreg cell differentiation culture, stimulated w
Gated on live CD4+ Foxp3+ cells. Differences not significant, unpaired, 2-tailed t-t
during 7-day iTreg cell differentiation culture, stimulated with 1 μg/ml MBP Ac1-frequency will be much lower, can still successfully be
differentiated into iTreg cells, CD4+CD62L+CD45.1+ Tg4 T
cells were titrated among non-transgenic naive B10.PL
CD45.2+ T cells down to 1 TCR-transgenic T cell in 100,000
and stimulated with 1 μg/ml MBP Ac1-9 in the presence of IL-2
and TGF-β. Even at the lowest ratio, antigen-specific Tg4
CD45.1+ T cells upregulated Foxp3 expression as effectively as
when all T cells were TCR transgenic, although the frequency of
Foxp3+ cells remained relatively low (Fig. 1). Clearly, the
number of single antigen-specific iTreg cells retrieved at the
end of the differentiation culture will be limited in a polyclonal
system. Optimization of the rate of Foxp3 induction in antigen-
specific T cells was therefore required.CD62L+ Tg4 T cells on plates coated with anti-CD3 and anti-CD28, with or
l at 10 μg/ml). Mean of triplicates + SEM. Each bar is representative of 3 or
t. B: Foxp3 induction in and proliferation of CPD-ef450-labeled CD4+ Tg4 T
ence of soluble anti-LFA-1,−CTLA-4 or -IL-10R at 10 μg/ml. Representative
-day culture with titrated amounts of MBP Ac1-9 and irradiated APC, with or
ive CD4+ cells. Bottom; median fluorescence of Foxp3 staining, gated on
b 0.001,2-tailed paired t-test. D: Proliferation and division indexes of T cells
ith 1 μg/ml MBP Ac1-9 with or without 10 μg/ml anti-LFA-1 in the culture.
est. E: LFA-1hi, CD4hi, CD62L, Ki67 and Foxp3 expression on live CD4+ T cells
9 and irradiated APC.
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differentiation
The induction of Foxp3 expression during thymic selection
is governed not only by the strength of TCR ligation, but also by
cytokines and co-factors including adhesion molecules and co-
stimulation (Verhagen et al., 2013b). In an attempt to enhance
Foxp3 induction in vitro, the effect of several co-factors on iTreg
cell differentiation was therefore examined. First, the effect of
antibodies to CTLA-4 (clone 9H10), PD-1 (clone J43), LFA-1
(CD11a, cloneM17/4) and LAG3 (clone C9B7W), all at 10 μg/ml
and either plate-bound or soluble, on Foxp3 induction in CD4+
T cells stimulated with anti-CD3 and anti-CD28 was assessed.
As depicted in Fig. 2A, ligation of LFA-1 with plate-bound
antibody significantly reduced Foxp3 expression, whereas
none of the other antibodies had a significant effect on Foxp3
induction. In the next step, the effect of soluble antibody to LFA-
1, CTLA-4 or IL-10R (clone 1B1.3A) on antigen-induced Foxp3
expression was assessed. As expected from the opposite effect
of plate-bound anti-LFA-1 on antibody-mediated iTreg cell
differentiation, this demonstrated that blockade of LFA-1 with
soluble antibody dramatically augmented Foxp3 induction in
Tg4 Tconv cells (Fig. 2B). In contrast, blockade of CTLA-4 had
only a modest inhibitory effect, while no consistent effect of IL-
10R blockadewas observed. Although LFA-1 activation is linked
to CTLA-4 signaling (Schneider et al., 2005), in our system the
reduction in Foxp3 expression in CTLA-4 deficient iTreg cells
could not be reversed using anti-LFA-1 (not shown). This is in
line, however, with the synergistic effects of anti-LFA-1 and
CTLA-4Ig observed in the inhibition of transplant graft rejection
(Reisman et al., 2011).
Considering the role of LFA-1 in the stable formation of the
immunological synapse and therefore the avidity of the T cell-
APC interaction, the effect of blockade of LFA-1 was hypothe-
sized to be tied to the strength of antigenic stimulation. To assess
this, CD4+CD62L+ Tg4 T cells were stimulated with a titrated
dose range of MBP Ac1-9 with or without soluble anti-LFA-1 in
the medium before determining the percentage of Foxp3
expressing cells as well as the mean level of Foxp3 expression
per cell (as expressed by the median fluorescence index (MFI))
on day 7. Anti-LFA-1 significantly augmented the percentage of
Foxp3-expressing cells over the range of peptide concentrations
tested but peaked at 1 μg/ml of peptide, where the mean
frequency of Foxp3 expression reached 87.6 ± 1.7%, n = 8
(Fig. 2C). The level of Foxp3 expression per cell was increased
significantly only at lower peptide concentrations, which could
be important as Foxp3 stabilizes its own expression (Gavin et al.,
2007). Without the addition of anti-LFA-1, the concentration of
peptide in the culture correlated inversely to the level of Foxp3
expression. Further lowering of the peptide concentration
below 0.1 μg/ml, however, did not sufficiently stimulate the
naive T cells in culture and, thus, did not give rise to sizeable
numbers of viable iTreg cells (not shown). Despite the
interference of stable immunological synapse formation that
will result from the inhibition of LFA-1 binding to ICAM-1, the
proliferation of CD4+ T cells over 7 days under iTreg cell
differentiation conditions is not impaired (Fig. 2D), resulting in a
high yield of iTreg cells. The blockade of LFA-1, therefore, does
not exert its effect by merely lowering the TCR signal but
actively changes the signaling involved in Foxp3 induction. This
may involve the blockade of LFA-1-mediated upregulation ofSmad7, SKI and SMURF2 that renders CD4+ T cells refractory to
TGF-β (Verma et al., 2012).
To gain a greater insight into the role of LFA-1 during iTreg
cell differentiation, its expressionwas assessed daily during the
7-day culture. As shown in Fig. 2E, although LFA-1 was
expressed on all CD4+ T cells, the level of expression was
differentially regulated on Foxp3− and Foxp3+ cells at the early
stages of antigen-mediated iTreg cell differentiation, correlat-
ingwith changes in the expression levels of CD4, CD62L and the
marker of cell division, Ki67. This could relate to the activation
status of the cells but, tantalizingly, this unequal distribution of
LFA-1, in conjunction with the TCR co-receptor CD4 and
coinciding with differential T cell proliferation, is also reminis-
cent of the recently described phenomenon of asymmetric cell
division (Chang et al., 2007; King et al., 2012). However, a role
for this process in iTreg cell differentiation is not supported by
the limited effect of variations in antigenic strength observed in
conditions with anti-LFA-1 (Fig. 2C). A direct effect of LFA-1
blockade on susceptibility to TGF-β signaling (Verma et al.,
2012) may, therefore, be the more likely explanation.
3.3. Anti-LFA-1 treatment alters the phenotype but not stability or
function of iTreg cells
As shown above, anti-LFA-1 treatment enhances the
efficacy of antigen-mediated iTreg cell differentiation but the
question remained whether this technique resulted in iTreg
cells not only of higher purity but also of equal or greater
functionality. First, the effect of anti-LFA-1 on the iTreg cell
phenotypewas assessed. Fig. 3A shows that CD62L, Neuropilin-
1 (NRP-1), CD103 and Helios, molecules commonly associated
with Treg cell function, were all expressed on a greater
proportion of iTreg cells differentiated in the presence of anti-
LFA-1 than in its absence. Next, the effect of LFA-1 blockade on
the stability of Foxp3 expression was assessed since instability
may be associated with undesirable immune responses
mediated by iTreg cells that have reverted to an effector
function. The stability of Foxp3 expression is regulated
primarily by demethylation of the CNS2 region of the foxp3
promoter (Zheng et al., 2010). In our model, iTreg cells
generated either with peptide and APCs or with plate-bound
anti-CD3 and anti-CD28 demonstrated a level of methylation
intermediate between that of Tconv cells and CD4+CD25+-
Foxp3+ splenic Treg cells (Fig. 3B). The addition of soluble anti-
LFA-1 during differentiation did not lower the level of
methylation and in the presence of the higher 10 μg dose of
MBP Ac1-9 may have even impaired demethylation. To
determine whether iTreg cells stably expressed Foxp3, iTreg
cells were generated, in the presence or absence of anti-LFA-1,
from naive T cells of male Tg4 Foxp3gfp mice (Verhagen et al.,
2013a), FACS-sorted to high purity and, after labeling with Cell
Proliferation Dye-ef450, transferred intraperitoneally to sex-
matched recipient Tg4 mice. After 48 h, these mice were
challengedwith a single dose of a highMHC II affinity variant of
the MBP Ac1-9 peptide (Ac-ASQYRPSQR). 72 h post-challenge
the transferred iTreg cells were recovered from the spleen and
analyzed for retention of Foxp3 expression, which had
diminished greatly, regardless of the addition of anti-LFA-1
during the iTreg cell differentiation culture (Fig. 3C). Although
the instability in this model may be augmented by the GFP-
Foxp3 fusion protein (Verhagen et al., 2013a), the in vivo
Fig. 3.Anti-LFA-1 treatment alters the phenotype but not the stability or function of iTreg cells. A: Expression of CD62L, Neuropilin-1 (NRP-1), CD103 andHelios on
Foxp3+ iTreg cells after 7-day differentiation culture with 1 μg/ml MBP Ac1-9 in the presence or absence of 10 μg/ml anti-LFA-1. Pooled data, n = 6–7 per
condition. **P b 0.01, *** P b 0.001,unpaired, 2-tailed t-test. B: Analysis of the relative level of methylation of 9 CpG in the foxp3 CNS2 region of naive CD4+ T cells,
CD4+CD25+ splenic Treg cells or iTreg cells generated under various conditions, in the presence or absence of 10 μg/ml soluble anti-LFA-1 (all Tg4). Blocks in each
column represent the mean values of three replicate samples. C: GFP-Foxp3 retention in Tg4 Foxp3gfp iTreg cells in vivo. FACS-sorted iTreg cells labeled with CPD-
ef450 were transferred to Tg4 recipients. Mice were challenged with a high affinity variant of MBP Ac1-9 48 h post transfer. 72 h post challenge iTreg cells
retrieved from the spleenwere analyzed for proliferation and Foxp3 retention by FACS. One experiment representative of 3 is shown. D: Tg4 mice received 5 × 106
Tg4 iTreg cells generated using either stimulation with 1 μl/ml MBP Ac1-9 and soluble anti-LFA-1 (Ag iTreg) or anti-CD3 and anti-CD28 (Ab iTreg) in PBS, or PBS
only, i.p. 3 days prior to EAE induction with MBP Ac1-9 in CFA and were monitored daily for disease. n = 3 per group, representative of 2 similar experiments.
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indicate that LFA-1 blockade during differentiation does not
offer iTreg cells greater stability of Foxp3 expression.
Despite a lack of CNS2 demethylation at levels akin to
naturally occurring CD4+CD25+ Treg cells and stability of
Foxp3 expression, adoptive transfer of antigen-specific iTreg
cells delayed the progression of CNS autoimmune disease.
To demonstrate this, Tg4 mice received 5 × 106 iTreg cells
intraperitoneally 3 days prior to EAE induction with MBP
Ac1-9 in CFA. As shown in Fig. 3D, Tg4 iTreg cells generated
using antigenic stimulation and anti-LFA-1 provided equal
levels of protection compared to anti-CD3 + anti-CD28-
induced Tg4 iTreg cells of similar purity, i.e. N90%.
Overall, we demonstrate here that functional iTreg cells can
be differentiated from self-antigen-specific Tconv cells by
in vitro stimulation with peptide in the presence of IL-2 and
TGF-β. Importantly, the efficacy of induction of Foxp3 expres-
sion is enhanced by the blockade of LFA-1 with monoclonal
antibody. This will facilitate the differentiation of greater
numbers of antigen-specific iTreg cells at high purity, thereby
improving the feasibility, efficacy and safety of iTreg cell-based
immunotherapy.
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